GHTC in the news

GHTC press releases, announcements, and press coverage are listed chronologically, starting with the most recent.

June 2014

NGOs Explore Role Of R&D In Post-2015 Agenda
SpyGhana.com
June 4, 2014 -- The Council on Health Research for Development (COHRED), along with the Global Health Council (GHC), the Drugs for Neglected Diseases initiative (DNDi), the International AIDS Vaccine Initiative(IAVI), and the Global Health Technologies Coalition (GHTC) hosted an official nongovernmental organization (NGO) side session at the 67th annual World Health Assembly (WHA) to explore the role of R&D in the post-2015 development agenda.

May 2014

NGO statement on the role of Research and Innovation to Achieve Health for All and Sustainable Development
COHRED, DNDi, GHTC, Global Health Council, and IAVI
May 22, 2014 -- Commitments to the Millennium Development Goals have made a major contribution to the success of global health efforts over the past decade, helping to sustain focus on some of the greatest global health challenges. The post-2015 development agenda must build on these achievements, to ensure that Healthy lives and access to health services for all can be achieved in an equitable and sustainable way.

Paper series examines key challenges and opportunities for nonprofit product developers
GHTC announcement
May 22, 2014 -- The Global Health Technologies Coalition (GHTC) today released the fifth and final paper and a summary of findings paper in its briefing series examining financing, accessibility, regulatory, and capacity issues facing nonprofits engaged in global health research and development (R&D).

April 2014

US underfunding crucial global health research and development, warns group
Humanosphere
April 9, 2014 -- As global health funding remains largely stagnant, more groups are trying to get a bigger piece of the US budgetary pie. For their part, research and development supporters wants a bigger slice, or at least for theirs to stay the same size.

Fears for global health R&D after US budget battle
SciDev.Net
April 4, 2014 -- Future research and development targeting diseases such as HIV, tuberculosis and malaria may be at risk because of across-the-board federal cuts implemented last year by the United States, the largest funder of global health R&D, warns a report.

Funding slowdown threatens US lead in global health R&D
PharmaTimes
April 1, 2014 -- A slowdown in federal government funding for the National Institutes of Health (NIH), as well as the volatile environment in Congress for annual budget appropriations, could over the longer term threaten US leadership in supporting global health research and development, a new report warns.

March 2014

Policy report asks for more US government involvement in global health research and development
Infectious Disease News
March 30, 2014 -- The Global Health Technologies Coalition released their annual policy report during a briefing last week in Washington, D.C. The report discusses the effects of cuts resulting from a sequestration, recommends budgets for federal health programs, and urges federal officials to become more involved in global health research and development, according to a press release from the group that represents more than 30 non-profit organizations.

Public Health in the News
NPHR blog
March 30, 2014 -- The Global Health Technologies Coalition has released its annual report, which warns against underfunding the National Institutes of Health in order to make sure necessary global health projects can continue.

Global Health Technologies Coalition warns against underfunded NIH
FierceHealthIT
March 28, 2014 -- While lauding a deal that halted the so-called "sequestration" budget cuts that would cripple global health programs, the Global Health Technologies Coalition warns against underfunding the National Institutes of Health.

Game changing investments in the fight against malaria
Making Malaria History
March 28, 2014 -- At a briefing on Capitol Hill last week, the Global Health Technologies Coalition launched its annual policy report, “Innovation for a changing world: The role of US leadership in global health R&D.” True to the nature of global health, the event panel included diverse representation from the nonprofit, government, business, and advocacy sectors.

Budget ceasefire helps the world at U. S. research expense
emaminer.com
March 27, 2014 -- The ceasefire in the Washington budget wars prompted in part by upcoming elections has improved the funding of health programs in other countries while reducing the funding to health research in the United States according to a March 27, 2014, policy report by Global Health Technologies Coalition, a coalition of nonprofit groups involved in health research in the United States and in majority funded by the federal government.

US budget’s neglect of National Institutes of Health is major concern
ctpost.com
March 27, 2014 -- While a ceasefire in Washington’s budget wars has restored funding for a range of programs targeting global health threats like AIDS and tuberculosis (TB), the simultaneous underfunding of the world’s biggest sponsor of global health research and development (R&D) puts future progress at risk, warns a new report from a coalition of nonprofit groups focused on advancing innovation to save lives. The Global Health Technologies Coalition (GHTC) released their annual policy report today at a Capitol Hill briefing.

Congress budget pact good for global health but NIH cuts threaten US innovations
Science Codex
March 27, 2014 -- While a ceasefire in Washington's budget wars has restored funding for a range of programs targeting global health threats like AIDS and tuberculosis (TB), the simultaneous underfunding of the world's biggest sponsor of global health research and development (R&D) puts future progress at risk, warns a new report from a coalition of nonprofit groups focused on advancing innovation to save lives.

Coalition Highlights Government's Role in Global Health Technology, Calls for NIH Funding Boost
Genome Web
March 27, 2014 -- The report from the Global Health Technologies Coalition, a group of non-profits focused on improving health in the developing world, spotlights the role US government, and NIH in particular, play in supporting research and development for therapeutic, diagnostic, and preventive tools to combat HIV/AIDS, malaria, tuberculosis, and other rare and tropical diseases.

Report: U.S. can do more to support global health R&D
FierceBiotechResearch
March 27, 2014 -- In the midst of flat funding for many federal programs as well as last year's across-the-board spending cuts known as sequestration, global health advocacy groups say Congress needs to adopt a long-term budget solution to sustain R&D activities for new drugs, vaccines and other health technologies to combat global health threats.

Report: US Essential for Global Health
Voice of America
March 27, 2014 -- A new report says while big budget battles in Washington may be over for now, adequate funding to fight HIV, TB, malaria and other diseases may still be at risk. The Global Health Technologies Coalition has released its annual report, which focuses on U.S. leadership in research and development.

US global health research funding falls short of innovation rhetoric — NGOs
Devex
March 27, 2014 -- On Thursday, the Global Health Technology Coalition will make its case on Capitol Hill in a Senate briefing aimed at convincing lawmakers that American global leadership demands funding for U.S. global health technologies and products — including low-cost vaccines, drugs, diagnostics and devices that can combat diseases endemic to the developing world.

New report from Global Health Technologies Coalition reveals a pipeline teeming with US-supported products, but neglect of National Institutes of Health is major concern
GHTC announcement
March 27, 2014 -- While a ceasefire in Washington’s budget wars has restored funding for a range of programs targeting global health threats like AIDS and tuberculosis (TB), the simultaneous underfunding of the world’s biggest sponsor of global health research and development (R&D) puts future progress at risk, warns a new report from a coalition of nonprofit groups focused on advancing innovation to save lives. The Global Health Technologies Coalition released their annual policy report today at a Capitol Hill briefing.

New paper outlines regulatory challenges for diseases of poverty
GHTC announcement
March 12, 2014 -- The Global Health Technologies Coalition (GHTC) today released a new paper providing unique insight into the regulatory barriers incurred by nonprofits in global health research and development (R&D). The paper examines the most significant challenges organizations face in navigating the regulatory landscape to advance the development of new vaccines, drugs, diagnostics, microbicides, and devices for low- and middle-income countries.

December 2013

Improving the affordability, availability, and acceptability of health technologies for low- and middle-income countries
Regulatory Focus
December 20, 2013 -- In order to achieve impact, a health technology must be more than just safe and effective. It must also be affordable, available, and acceptable to ensure that it is accessible to those who need it most.

Paper examines access to new tools for diseases of poverty
GHTC announcement
December 13, 2013 -- The Global Health Technologies Coalition (GHTC) today released a new paper shedding new light on issues surrounding access to global health products. The paper examines how organizations that advance the development of new vaccines, drugs, diagnostics, microbicides, and other health products for low- and middle-income countries (LMICs) ensure access to the tools and technologies they develop.

September 2013

As funding declines for nonprofit product development targeting global health concerns, innovation becomes key for financing
Science Speaks
September 12, 2013 -- They target a seemingly diverse range of conditions — tuberculosis, HIV and malaria, along with illnesses long ignored outside of where their impact is felt — African trypanosomiasis, lieshmaniasis, Chagas disease — but they are linked by this: They are products without profitable commercial markets in the places for which they are developed.

Paper examines R&D funding for diseases of poverty
GHTC announcement
September 12, 2013 -- The Global Health Technologies Coalition (GHTC) today released a new paper that provides unique insight into the funding landscape for global health research and development (R&D). The paper examines key financing challenges and opportunities facing organizations that advance the development of new vaccines, drugs, diagnostics, microbicides, and other health products for low- and middle-income countries (LMICs).

July 2013

Can collaboration resuscitate global health funding?
The Guardian
July 31, 2013 -- As support for global health projects declines, governments, NGOs and the private sector will have to be creative and commit to collaboration.

May 2013

A Notable Report on PDP Challenges
IAVIReport
May 16, 2013 -- IAVI Report readers might find this paper released by the Global Health Technologies Coalition interesting. It looks at the challenges faced by organizations working on solutions for diseases associated with poverty.

Paper provides new insights into primary obstacles hindering R&D for diseases of poverty
GHTC announcement
May 16, 2013 -- The Global Health Technologies Coalition (GHTC) today released a paper that provides new and comprehensive insights into the challenges facing organizations that advance research and development (R&D) for neglected diseases. The paper—titled Financing and Coordination of Health Research: Perspectives from Nonprofits on Accelerating Product Development and Improving Access for Low- and Middle-Income Countriesalso offers concrete solutions to these obstacles.

April 2013

As Sequestration Slashes Drug Research Funding, Drug-Resistant Malaria Emerges
Think Progress
April 30, 2013 -- Malaria kills hundreds of thousands, if not millions, of people every year. It’s the fifth-leading killer in the developing world, according to the World Health Organization (WHO). And according to a worrying new study, a new strain of the disease is evolving that resists the treatment typically used to combat it — just as budget cuts in the United States are cutting off massive amounts of funding for research to develop new drugs.

March 2013

Sequester cuts set to hit vaccines
Fierce Vaccines
March 7, 2013 -- Deep federal spending cuts triggered by sequestration are set to rock vaccine development and administration in the U.S. and beyond. The White House warns that the cuts will limit the number of vaccines federal agencies buy from GlaxoSmithKline, Merck, Sanofi, and other manufacturers.

Opinion: An Uncertain Future
The Scientist
March 6, 2013 -- We at the Global Health Technologies Coalition (GHTC) have been inspired this year by a number of scientific breakthroughs designed to combat some of the greatest public health scourges across the globe.

US budget cuts could impact drug development for TB, HIV/AIDS
Vaccine News
March 1, 2013 -- Cuts to research and development programs could jeopardize the development efforts of new drugs for TB, HIV/AIDS and malaria, according to a recent report from the Global Health Technologies Coalition.

February 2013

GHTC report warns against R&D cuts in US
Vaccine Nation
February 28, 2013 -- Cuts to the R&D programmes in the United States (US) could have a devastating impact on a number of important healthcare initiatives, including the world’s first malaria vaccine.

Sequestration will be hazardous to our health
MSNBC
February 28, 2013 -- Sequestration will trigger $2.6 billion in annual cuts to the State Department and USAID, eliminating $600 million in humanitarian assistance and global health programs. These are piddling amounts by domestic standards, but the impact could be devastating because the affected programs provide lifesaving assistance to people already battered by war, famine and disease.

Cuts to foreign assistance will hurt global health advancements
ONE Blog
February 28, 2013 -- As I’m sure you all can imagine, it’s been a busy week in Congress. With the budget debate still going strong and sequestration looking more and more likely, all US-funded programs are on the chopping block.

ASTMH Helps Kick Off Global Health Week in Washington
ASTMH Blog
February 27, 2013 -- Proposed budget cuts to U.S. research and development programs could have a devastating impact on global health research in particular. Specifically, current efforts to develop new tuberculosis drugs, the world's first malaria vaccine, and other vital global health products in development are among the projects that could be in jeopardy, according to a new report from the Global Health Technologies Coalition (GHTC), of which ASTMH is a member.

GHTC Briefing Highlights Importance of Federally Funded Global Health Research
Research!America Blog
February 27, 2013 -- On February 26, the Global Health Technologies Coalition held a Capitol Hill briefing, “Renewing US leadership: Policies to advance global health research.” The briefing included displays from global health nonprofits, the launch of GHTC’s fourth annual policy report as well as a panel discussion.

What Does the Sequester Mean for Global Health?
Action.org Blog
February 27, 2013 -- Sequestration cuts are bearing down on the U.S. government -- just two more days. With all the media coverage of these cuts' potential impacts, does the sequester feel intangible? Incomprehensible?

Last Ditch Effort to Preserve US Global Health R&D Spending
Humanosphere
February 27, 2013 -- Sequestration hits the US federal budget on Friday. The Washington Post features a countdown to Friday on the front page each day. News reports and the talk around town radiates a certainty that the across the board budget cuts will go through on Friday.

GHTC Report Warns Of Cuts To US Global Health Funding, Provides Steps To Strengthen Global Health R&D
Kaiser Global Health Policy Report
February 27, 2013 -- According to a new report released Tuesday by the Global Health Technologies Coalition (GHTC), a U.S. umbrella group, sequestration could shrink global health spending at the State Department and USAID," as well as the National Institutes of Health.

The Daily Impact: Advocates Call For Keeping Up Global Health Funding
PSI Impact Blog
February 27, 2013 -- A report presented by the Global Health Technologies Coalition in Washington DC yesterday urged the USA to keep up global health spending.

US budget cuts imperil domestic and global biomedical research
Nature
February 26, 2013 -- In the medical world, the term ‘sequestration’ is usually preceded by the word ‘pulmonary’ or ‘splenic’ and is used to describe rare diseases that are the focus of research grants funded by the US National Institutes of Health (NIH). But sequestration has now taken on a new meaning.

Budget sequester: Cuts would hit vaccination, elderly meals, childcare
NBC News
February 26, 2013 -- Four thousand children in Georgia who won’t get free vaccines. More than 2,000 food safety inspections cancelled. Four million meals that won’t go to homebound seniors. The Obama administration is scrambling in the last few days to gin up pressure on Republican members of Congress who increasingly look like they will willingly let what was supposed to have been unthinkable – a budget sequester – happen by Friday.

Advocates urge US to maintain global health funds
The Hill
February 26, 2013 -- The United States must maintain its investments in global health despite the threat of sequestration and calls for deficit reduction, advocates said Tuesday.

Africa: New Report Highlights Advances in Global Health Research and Development
allAfrica
February 26, 2013 -- The Global Health Technologies Coalition (GHTC) has released its fourth annual policy report, documenting US leadership in driving global health research and development to save lives around the world.

Global Health Experience to Vist DC For The First Time During "Global Health Week on the Hill"
Global Imapct
February 26, 2013 -- The Global Health Experience, which drew thousands of visitors in Seattle, makes its first trip to Washington, D.C. this week. Nine organizations are partnering to bring the exhibit to the East Coast in order to draw congressional focus to global health during “Global Health Week on the Hill”, February 26-March 5, 2013.

US Cuts to Global Health Budget "Mass-scale Malpractice"
Inter Press Service
February 26, 2013 -- Public health workers, activists and policymakers are stepping up a last-minute campaign to highlight the global health impact of historic, sweeping cuts to the U.S. federal budget due to go into effect Friday if Congress doesn’t act.

New report highlights advances in global health research and development
PATH
February 26, 2013 -- The Global Health Technologies Coalition (GHTC) has released its fourth annual policy report, documenting US leadership in driving global health research and development to save lives around the world.

Week ahead: Slew of healthcare issues await lawmakers
Healthwatch
February 25, 2013 -- Forget the sequester — with Congress back in town this week, there are a bevy of healthcare events concerning everything from delivery-system reform to global health diplomacy.

US Cuts Could Jeopardize Global Health Innovations, Says Report
PharmExec.com
February 20, 2013 -- Cuts to US global health and research programs for diseases such as AIDS, tuberculosis and malaria risk derailing the innovations crucial to fighting these diseases, according a new report by the Global Health Technologies Coalition.

July 2012

AIDS 2012: Time to recognize and recommit US support for R&D
One
July 12, 2012 -- As the International AIDS Conference descends on DC later this month — the first time this conference has been held in the United States in over 20 years — there couldn’t be a better time to reflect on the scientific gains that have emerged over the past several months, and how a wide range of dedicated Americans are pushing this HIV/AIDS research forward.

June 2012

Q and A with Mary Woolley, President of Research!America
Global Health Matters
June 2012 -- Global health research funding not only brings humanitarian benefits but is also a powerful driver of U.S. economic activity.

US economy benefits from global health research
Global Health Matters
June 2012 -- U.S. global health research funding not only produces humanitarian benefits, improving and saving millions of lives worldwide, but also generates significant domestic economic activity and spurs scientific innovation.

Pharma backs latest attempt at a global health R&D treaty
Nature
June 6, 2012 -- Philanthropists, drugmakers and governments all agree: the world's poor are in dire need of new drugs for neglected diseases, but there is not enough money available to develop innovative treatments.

May 2012

Global health needs extend beyond HIV/AIDS R&D
BioWorld
May 29, 2012 -- A singular focus on HIV/AIDS and a lag in translating medical discoveries into approvable medicines could be keeping the U.S. from getting its money's worth from R&D aimed at addressing the most pressing global health needs.

Global health research needs to focus on clinical trials to deliver products for patients, says report
BMJ
May 18, 2012 -- The report finds that all stages of research—from early science to the later stages of product development—are critical to the successful creation of new global health tools.

Funding for Global Health Research Boosts Development, U.S. Economy
LillyPad
May 4, 2012 -- Last Friday, the Global Health Technologies Coalition released a report on the health and economic benefits of U.S. government investments in global health research and development.

US should fund more late-stage health R&D, says report
SciDev
May 4, 2012 -- The United States should encourage more public-private partnerships and increase its late-stage research funding, to improve the translation of research into products to fight neglected diseases, according to a report launched last week.

US government leads global health R&D funding, report finds
PharmaTimes
May 3, 2012 -- The US government is the world’s leading funder of global health research and development, investing more than US$12.7 billion over the past 10 years in new vaccines, drugs, diagnostics and other products for neglected diseases of the developing world, a new report has found.

Report: Funding Global Health Helps US Economy Grow
Voice of America
May 3, 2012 -- A new report by a coalition of global health groups says the United States is the world's top economic supporter of global health research and development. Not only is that a boost for the fight against disease, the report says, it's also good for the U.S. economy.

Report: FDA Increasingly Playing Key Role in Global Health
Regulatory Focus
May 1, 2012 -- A report issued by the Global Health Technologies Coalition (GHTC), a coalition of 40 non-profit groups including the Bill & Melinda Gates Foundation, argues that the US Food and Drug Administration’s (FDA) effects are being felt far beyond US borders.

U.S. Government Is Largest Funder Of Global Health R&D, Report Shows
Kaiser Family Foundation
May 1, 2012 -- "The U.S. government is the largest funder of global health research and development [R&D] in the world, spending $12.7 billion over the past 10 years," according to a report (.pdf) released on Friday by the Global Health Technologies Coalition (GHTC) and Policy Cures.

U.S. government is largest funder of global health research
Vaccine News
May 1, 2012 -- The United States government is the largest funder of worldwide health research and development, accounting for 45 percent of total global investment.

April 2012

U.S. is world’s largest funder of global health research and development
Science Speaks
April 30, 2012 -- The U.S. government invested $12.7 billion over the past decade in the creation of new vaccines, drugs, diagnostics and other products for neglected diseases in the developing world. That’s according to a new report released by the Global Health Technologies Coalition

Saving lives and creating impact : Global Health Technologies Coalition
Biotechnology Trend
April 30, 2012 -- This report aims to assess the impact of past US Government investments in global health R&D and to review the role of ongoing US Government investments in global health R&D.

New report reveals why investing in global health research works
Research!America
April 30, 2012 -- With all eyes focused on federal deficit reduction, global health programs—including research and development for vaccines, drugs and diagnostics—are in danger.

U.S. largest funder of health research
United Press International
April 29, 2012 -- The U.S. government is the largest funder of global health research and development in the world, spending $12.7 billion over the past 10 years, a group says.

GHTC, Policy Cures report US Govt as largest funder of global health R&D worldwide
Pharmabiz.com
April 28, 2012 -- A news report jointly released by the Global Health Technologies Coalition (GHTC) and Policy Cures recently claimed that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world.

Global health research needs to focus on clinical trials to deliver products for patients, says report
BMJ
April 27, 2012 -- The US government provided about $12.7bn (£7.8bn; €9.5bn) in global health research over the past decade, 45% of total world investment and 70% of all government investment in the field, says the report.

New report finds that the US Government is the largest funder of global health R&D worldwide
TB Online
April 27, 2012 -- A new report finds that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world.

US Investment Saving Lives Around the World
Voice of America
April 27, 2012 -- A new report says the U.S. government is the world leader when it comes to investing in global health research and development. Over the past 10 years, the U.S. has provided nearly 13 billion dollars for new vaccines, drugs and equipment to fight diseases in developing countries.

New report finds that the US Government is the largest funder of global health R&D worldwide
GHTC press release
April 27, 2012 -- A new report finds that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world.

Global Health Funding Crisis Hits UN Work
The InterDependent
April 10, 2012 -- Almost as soon as the global financial crisis struck in 2008, policymakers began raising concerns that recession could start to undo the gains in poverty reduction of the last decade.

March 2012

Report, Panelists Warn Budget Cuts Could Hurt Global Health Programs
Bloomberg BNA
March 7, 2012 -- Deep federal budget cuts could reverse the dramatic progress in the fight against disease in the United States and abroad, according to a report released Feb. 28 by the Global Health Technologies Coalition (GHTC).

Global Health Leaders Discuss Global Health Innovation
Boston University “LEED” Blog
March 5, 2012 -- After the release of the Obama Administration’s budget for 2013 and the resulting cuts from several global health programs, global health leaders met at a congressional briefing to discuss the importance of global health innovation and the United States’ consequent role.

Research Report: Sustaining Progress – Creating US Policies to Spur Global Health Innovation
Center for Vaccine Ethics and Policy Blog
March 4, 2012 -- GHTC released its third annual policy report which documents US leadership in driving the research and development that saves lives around the world.

Global Health Leaders Discuss Need for Global Health Innovation at Congressional Briefing
Science Speaks
March 1, 2012 -- The Global Health Technologies Coalition (GHTC) has released their annual policy report, “Sustaining Progress: Creating US policies to spur global health innovation,” which outlines crucial advances made in global health research and development, thanks to U.S.-government investment.

U.S. Congress Faces Funding Decision on HIV, Malaria
“Impatient Optimist”
March 1, 2012 -- When Risper Kageha became pregnant two years ago in western Kenya, a nurse tested her for HIV. The result came back positive, so health workers immediately started her on life-extending antiretroviral drugs. Soon after, when her daughter Sylvia was born, both mother and child were given a dose of nevirapine in a successful effort to prevent the transmission of the virus from Risper to Sylvia.

February 2012

What We’re Reading: The global health president
ONE Blog
February 29, 2012 -- The Global Health Technologies Coalition has released a report intended for members of Congress and the Obama administration “warning deep cuts in the U.S. federal budget could reverse progress made on many diseases, including HIV/AIDS, tuberculosis and malaria.”

US Congress urged not to cut global health funding
SciDev.net
February 29, 2012 -- Proposed US cuts to funding for global health research and development could scupper gains made in tackling diseases such as HIV/AIDS, malaria and tuberculosis, warns a report released yesterday (28 February).

All for One, One for All
Bio Ventures for Global Health blog
February 29, 2012 -- We heard this over and over again during yesterday's Global Health Technologies Coalition (GHTC) briefing. The message is clear: millions of lives have been saved across the globe because of American innovation.

New report warns of setbacks in global health progress due to current budget climate
GHTC press release
February 28, 2012 -- The prospect of deep cuts in the federal budget threatens to reverse the dramatic progress of a bipartisan US commitment to defeat neglected diseases in developing countries, according to a new report released today by the Global Health Technologies Coalition (GHTC).

US senator on global health: ‘Achievable stuff’
GlobalPost’s "Global Pulse"
February 28, 2012 -- For those in the global health world — and there are many in the nation’s capital — one common question is why in tight budgetary times should Congress support spending on research and development to fight diseases around the world.

US Government Urged to Maintain Global Health Spending
Voice of America
February 28, 2012 -- Health-related groups are warning deep cuts in the U.S. federal budget could reverse progress made on many diseases, including HIV/AIDS, tuberculosis and malaria.

GHTC releases policy recommendations
PATH.org
February 28, 2012 -- The Global Health Technologies Coalition (GHTC) has released its third annual policy report, which documents US leadership in driving the research and development that saves lives around the world.

Why care about research? Ask Whoopi.
PATH blog
February 28, 2012 -- The Global Health Technologies Coalition (GHTC) recently approached prominent people in Washington, DC, and asked them to give the rest of Americans a reason to care about research in global health.

Video: Health Research and Development in Kenya
USAID’s “Impact Blog”
February 28, 2012 -- USAID’s  health research strategy (PDF) includes assessing health conditions in developing countries and developing, testing, adapting, and introducing appropriate products and interventions within the context of strengthening local health systems. See that strategy in action in this new video from Global Health Technologies Coalition about our health research and development work in Kenya.

The Transformative Power of Global Health Research
Research!America Blog
February 28, 2012 -- American scientists have fueled recent research breakthroughs—from new approaches to preventing the spread of HIV to protecting children from malaria and meningitis. However, the prospect of deep cuts in the federal budget threatens to reverse or halt such progress.

US research abroad as a catalyst for life-saving breakthroughs
AMSA's Global Health Journal "Global Pulse"
February 28, 2012 -- A new video from the Global Health Technologies Coalition explores global health research resulting from US investments in Kenya.

December 2011

Donor governments stop short of crossing the ‘finish line’ in global health
The Hill’s “Congress Blog”
December 12, 2011 -- Over the last decade, great progress has been made in developing new global health technologies that show potential to transform the deadliest diseases on earth. This progress has been delivered largely by Product Development Partnerships (PDPs), with critical support from the public, private and philanthropic sectors, which have filled the gap by developing new technologies to prevent, diagnose and treat diseases affecting the world’s most underserved populations.

November 2011

Four game-changing HIV/AIDS treatments
The ONE Blog
November 16, 2011 -- The past three years have been historic in the number of breakthroughs in research to prevent, diagnose and treat HIV and AIDS. For the first time, researchers proved that an HIV vaccine could prevent infection; an HIV prevention gel called a microbicide was shown to prevent infection among women; studies showed that a once-daily pill could reduce the risk of infection in high-risk individuals; and antiretroviral treatment among HIV-positive individuals was proven to reduce the risk of infecting their partners.

Why should Americans care about global health?
GlobalPost
November 7, 2011 -- On Tuesday, Secretary of State Hillary Clinton will be delivering a major speech on the HIV/AIDS pandemic at the National Institutes of Health. Clinton’s speech is expected to highlight US leadership in research and innovation for HIV/AIDS, particularly in developing treatment and prevention tools. Against that backdrop, the Global Health Technologies Coalition (GHTC), a Washington, D.C.-based advocacy group promoting global health research and development, interviewed prominent Americans and leading US health officials on why Americans should care about the issue.

September 2011

Contagion and the need for health research
The Hill’s “Congress Blog”
September 14, 2011 -- The promos for the movie Contagion, the No. 1 box office hit last weekend, a thriller about the deadly spread of a killer virus and scientists’ race to stop it, is full of frightful scenes. One shows the shocked faces of Matt Damon and Gwyneth Paltrow. Another part flashes these words: “One touch. Transmission.”

US budget quagmire leaves global health funding in the lurch
Nature Medicine
September 7, 2011 -- In August, after a tense run-up to the default deadline, US lawmakers passed the Budget Control Act. The legislation that increased the debt ceiling contains $917 billion in cuts through 2021, which will probably affect core research agencies such as the National Institutes of Health, the National Science Foundation and the science office of the Department of Defense. But individuals involved in global health programs are also bracing for a hit come September, when Congress scrutinizes how to appropriate next year's federal budget, given the nation's tightened purse strings.

June 2011

Report Calls for US Funding to Speed Global Health Research and Innovation
JAMA
June 15, 2011 -- A coalition of 30 nonprofit health organizations promoting the development of drugs, vaccines, and other health-related products designed for use in the developing world is calling on US policymakers and regulators to accelerate scientific innovation and streamline the approval process for safe and affordable new medical products that can be used worldwide. 

May 2011

Castle and Christenson: Find Common Ground In Medical Research
Roll Call
May 25, 2011 -- In the coming weeks and months, the budget battles in Congress for 2012 will likely grow even more acrimonious. But if there’s any hope of finding some compromise between the Democrats and Republicans, it may be in a little-known area of common ground — medical research, and particularly the exciting discoveries that are on the verge of making breakthroughs in fighting diseases that have plagued humankind for hundreds of years.

Q & A with Dr. Alex Dehgan, USAID
Global Health Magazine blog
May 2, 2011 -- Dr. Alex Dehgan, PhD, MSc, JD, is the science and technology advisor to the administrator of the US Agency for International Development (USAID), and heads the office of science and technology within the new bureau of policy, planning, and learning.

Q & A with Dr. Gita Ramjee, South African Medical Research Council
Global Health Magazine blog
May 3, 2011 -- Dr. Gita Ramjee is a world-renowned scientist specializing in HIV prevention, treatment, and care. Dr. Ramjee is the director of the South African Medical Research Council's HIV prevention program and has been involved in the clinical trials of microbicides for over a decade.

Q & A with Dr. Nelson L. Michael, US MRHP
Global Health Magazine blog
May 4, 2011 -- Nelson L. Michael, MD, PhD, a Colonel in the US Army Medical Corps, is the director of the US Military HIV Research Program at the Department of Defense's Walter Reed Army Institute of Research in Rockville, Maryland.

Leading global health groups call on US to accelerate research
GHTC press release
May 4, 2011 -- A coalition of 30 leading global health organizations that work on vaccines, drugs, and other tools and technologies that save lives today released a list of recommendations for US policymakers and regulators, calling for acceleration of scientific innovations and streamlining the approval of safe and affordable inventions in order to save more lives around the world.

Q & A with Dr. Roma Chilengi, KEMRI
Global Health Magazine blog
May 5, 2011 -- Dr. Roma Chilengi was the head of clinical trials at the Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme in Kilifi, Kenya, from 2008 until April 2011. While he worked on several vaccine trials, Chilengi specialized in malaria vaccine research and was the coordinator of programs and trials at the African Malaria Network Trust.

March 2011

Meeting the world’s health challenges, boosting our economy
The Hill’s “Congress Blog”
March 8, 2011 -- American innovations that improve the health of all people on earth can come from anywhere, even from sending people to outer space. NASA developed a water-filter system devised for the space shuttle that kills bacteria using iodine resin. Now that system is being used to purify water in some of the poorest countries in the world, saving countless families from debilitating diseases.

Research frontlines: Christenson speaks to advancing global health technologies
Science Speaks
March 8, 2011 -- In the areas of HIV and TB research, what do you see as big news ahead? About a third of our coalition members are conducting research on a variety of global health diseases, and several of them work in HIV or TB. In general, over the past decade, we’ve made some major advances against HIV and TB, but it’s clear that without new technologies being researched and developed, we do not have the tools we need to fight these diseases.

February 2011

Shah’s Speech at NIH: Delivering Dramatic, Sustainable Global Health Gains
ModernizeAid blog
February 16, 2011 -- Before US Agency for International Development (USAID) Administrator Rajiv Shah uttered the first word of his National Institutes of Health (NIH) Barmes Lecture today, NIH Director Francis Collins called attention to the symbolism of the moment: He said it marked the first time that a sitting USAID leader had spoken at NIH.

December 2010

U.S. support key to recent breakthroughs in global health science
Science Speaks
December 10, 2010 -- The news briefings in London and Geneva earlier this week were thrilling: the World Health Organization (WHO) announced that it endorsed a new, faster diagnostic test for TB. The test could transform TB care and control by giving results that detect a drug-resistant form of the disease in less than two hours, compared with current tests that can take up to three months.

November 2010

iPrEx results are in; Six experts offer thoughts
Science Speaks
November 23, 2010 -- Today The New England Journal of Medicine released the positive results of the Pre-exposure Prophylaxis Initiative (iPrEx) trial, which looked at whether daily oral dosing of two FDA-approved antiretroviral (ARV) medications used to treat HIV/AIDS – tenofovir and emtricitabine, combined in one tablet (Truvada) – can prevent HIV transmission in high-risk populations.

October 2010

Do prizes offer enough incentive to drive global health product development?
Center for Global Health R&D Policy Assessment blog
October 26, 2010 -- On Wednesday, I participated in a well attended and engaging discussion during which Results for Development Institute (R4D) presented some of their initial analysis of this very question. The discussion was part of an ongoing project at R4D to explore the pros and cons of different incentives under consideration right now to spur the development of new products for global health.

Innovation in the GHI: How science and research can make foreign aid more effective
ModernizeAid
October 14, 2010 -- “There is too little innovation focused on designing technologies and strategies that can work in resource-poor places and help the people who are hardest to reach,” Secretary of State Hillary Rodham Clinton said during a recent speech on the Global Health Initiative (GHI). She added that the GHI is “investing in innovation, with a focus on developing tools that will help diagnose, prevent, and cure disease in the communities where we work, which are often remote and poor in resources.”

September 2010

Coalition of leading international health groups releases recommendations to elevate FDA's role in global health
GHTC press release
September 23, 2010 -- The Global Health Technologies Coalition (GHTC), a group of more than 30 leading international health organizations, today released recommendations to elevate the role of the US Food and Drug Administration (FDA) in global health. The GHTC released its recommendations at a pivotal hearing hosted by the FDA to examine its role in regulating and reviewing crucial global health products, such as vaccines, drugs, microbicides, diagnostics, and other tools that save lives worldwide.

June 2010

Restoring U.S. foreign aid to health
The Hill’s “Congress Blog”
June 1, 2010 -- President Obama, his foreign policy team, and Congress are on the cusp of redefining how the United States approaches foreign assistance. As they undertake their aid reform effort this year, they're promising to get serious about ensuring that American funds are used wisely.

April 2010

GHTC issues recommendations for Congress, Administration
GHTC announcement
April 21, 2010 -- The Global Health Technologies Coalition (GHTC) recently released its first annual policy report, which provides recommendations for Congress and the Administration on how to position the United States as the leader in a worldwide movement to strengthen global health research and development (R&D).

March 2010

Global Health Technologies Coalition calls for US engagement in innovative effort to bring vaccines to children worldwide
GHTC press statement
March 23, 2010 -- GlaxoSmithKline (GSK) and Pfizer today announced that they have joined the first Advance Market Commitment (AMC), a unique funding effort to bring pneumococcal vaccines to millions of children worldwide. The Global Health Technologies Coalition (GHTC) commends increased involvement in the AMC and calls on the United States to participate in innovative health financing mechanisms, including a future AMC, to maximize the life-saving potential of immunizations worldwide.

CSIS Commission report highlights need for global health research, innovative financing
GHTC press statement
March 18, 2010 -- The Center for Strategic and International Studies (CSIS) today released the final report of its Commission on Smart Global Health Policy, providing recommendations for US policymakers on creating a long-term and strategic approach to global health. The bi-partisan commission includes several influential global health experts, including Dr. Helene Gayle, President and CEO of CARE; Admiral William J. Fallon (retired); former Senate Majority Leader Bill Frist (R-Tenn.); Sen. Olympia Snowe (R-Maine); and former UNAIDS Head Dr. Peter Piot.

February 2010

Global Health Technologies Coalition applauds White House budget proposal
GHTC press statement
February 1, 2010 -- President Obama's fiscal year 2011 budget proposal clearly demonstrates that the White House is committed to research and development (R&D) and global health issues by increasing funding for several key US agencies. The Global Health Technologies Coalition (GHTC) applauds this commitment to innovation and urges the Obama administration to continue to bolster and integrate its investment in R&D. 

December 2009

Groundbreaking survey of funding for global health research and development released in India
GHTC press statement
December 16, 2009 -- The Global Health Technologies Coalition (GHTC), a group of more than 30 nonprofit organizations dedicated to increasing US support and funding for global health research and development (R&D), commends the release of the 2009 Global Funding of Innovation for Neglected Disease (G-FINDER) survey created by the George Institute for International Health. The G-FINDER is the only annual global survey of public and private investments into R&D for neglected diseases.

September 2009

New report demonstrates power of vaccines and immunizations worldwide
GHTC press statement
September 21, 2009 -- The report released today by the World Health Organization, United Nations Children’s Fund, and World Bank demonstrates the power of immunization to improve child and maternal health in the developing world. The State of the World’s Vaccines and Immunizations (SOWVI) documents the substantial gains in global health and life-expectancy that have been achieved through widespread availability of lifesaving vaccines.

May 2009

GHTC receives funding to encourage new health solutions for the developing world
GHTC press release
May 15, 2009 -- A coalition of over two dozen nonprofit organizations working to accelerate the development and delivery of new health products to prevent HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases has received a three-year grant from the Bill & Melinda Gates Foundation. The Global Health Technologies Coalition works to educate US policymakers about the benefits of new vaccines, microbicides, drugs, and diagnostics to improve health in developing countries.

Sign up for the GHTC newsletter Follow us

Home | Contact us | Privacy policy | Copyright policy

© 2009–2014, Global Health Technologies Coalition.